# Exozymes Inc.: Form 8-K, filed Feb 5, 2026

- Company: [Exozymes Inc.](/companies/exoz.md) (CIK 2010788)
- Form: 8-K
- Filed: 2026-02-05
- Accepted by EDGAR: Feb 4, 2026, 21:30 ET
- Period: 2026-01-29
- Accession: 0001493152-26-005176
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2010788/000149315226005176/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2010788/000149315226005176/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2010788/000149315226005176/form8-k.htm

Filed Feb 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-005176. Last ingested by Listed: Oct 26, 2026, 15:02 ET. No prices; not investment advice.